Marta Baleva

2.3k total citations
19 papers, 131 citations indexed

About

Marta Baleva is a scholar working on Rheumatology, Immunology and Epidemiology. According to data from OpenAlex, Marta Baleva has authored 19 papers receiving a total of 131 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Rheumatology, 5 papers in Immunology and 4 papers in Epidemiology. Recurrent topics in Marta Baleva's work include Systemic Lupus Erythematosus Research (7 papers), Immune Cell Function and Interaction (3 papers) and Urticaria and Related Conditions (2 papers). Marta Baleva is often cited by papers focused on Systemic Lupus Erythematosus Research (7 papers), Immune Cell Function and Interaction (3 papers) and Urticaria and Related Conditions (2 papers). Marta Baleva collaborates with scholars based in Bulgaria, Hungary and Egypt. Marta Baleva's co-authors include Maria Nikolova, Anna Erdei, József Prechl, Andrey Tchorbanov, Elisaveta Voynova, Tchavdar L. Vassilev, Ivan Grozdev, Nikolina Mihaylova, Lyubomir Dourmishev and Elissaveta Naumova and has published in prestigious journals such as SHILAP Revista de lepidopterología, European Journal of Immunology and BioMed Research International.

In The Last Decade

Marta Baleva

18 papers receiving 126 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marta Baleva Bulgaria 7 69 47 25 20 20 19 131
Antonio Gil‐Aguado Spain 7 33 0.5× 85 1.8× 27 1.1× 13 0.7× 14 0.7× 12 160
Rosa Serrano Spain 6 52 0.8× 101 2.1× 18 0.7× 10 0.5× 18 0.9× 11 167
Márta Bocskai Hungary 6 35 0.5× 46 1.0× 29 1.2× 27 1.4× 10 0.5× 7 127
J.J. Pérez-Venegas Spain 6 95 1.4× 72 1.5× 26 1.0× 13 0.7× 9 0.5× 10 149
A. Canossi Italy 9 173 2.5× 34 0.7× 17 0.7× 29 1.4× 28 1.4× 42 256
Biljana Brezina United Kingdom 4 55 0.8× 85 1.8× 18 0.7× 21 1.1× 15 0.8× 7 143
Christina Papista France 6 84 1.2× 23 0.5× 17 0.7× 41 2.0× 41 2.0× 6 287
Giovanni Cagnotto Sweden 4 30 0.4× 76 1.6× 9 0.4× 9 0.5× 10 0.5× 12 130
Lorraine Pui Yuen Kwan Hong Kong 5 57 0.8× 130 2.8× 18 0.7× 11 0.6× 10 0.5× 9 163
Inmaculada Farrán-Codina Spain 7 41 0.6× 36 0.8× 6 0.2× 28 1.4× 9 0.5× 10 132

Countries citing papers authored by Marta Baleva

Since Specialization
Citations

This map shows the geographic impact of Marta Baleva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marta Baleva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marta Baleva more than expected).

Fields of papers citing papers by Marta Baleva

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marta Baleva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marta Baleva. The network helps show where Marta Baleva may publish in the future.

Co-authorship network of co-authors of Marta Baleva

This figure shows the co-authorship network connecting the top 25 collaborators of Marta Baleva. A scholar is included among the top collaborators of Marta Baleva based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marta Baleva. Marta Baleva is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Baleva, Marta, et al.. (2022). Durability of humoral and cell‐mediated immune response after SARS‐CoV‐2 mRNA vaccine administration. Journal of Medical Virology. 95(1). e28360–e28360. 7 indexed citations
2.
3.
Petrova, Guergana, et al.. (2020). On Two Cases with Autosomal Dominant Hyper IgE Syndrome: Importance of Immunological Parameters for Clinical Course and Follow-Up. SHILAP Revista de lepidopterología. 2020. 1–9. 4 indexed citations
4.
Baleva, Marta, et al.. (2017). Immune Cell Subsets Evaluation as a Predictive Tool for Hepatitis B Infection Outcome and Treatment Responsiveness. Folia Medica. 59(1). 53–62. 5 indexed citations
5.
Baleva, Marta, et al.. (2016). A rare case of Addison’s disease, hepatitis, thyreoiditis, positive IgG anti-tissue transglutaminase antibodies and partial IgA deficiency. Central European Journal of Immunology. 41(2). 217–220. 2 indexed citations
6.
Baleva, Marta, et al.. (2015). Antiphospholipid antibodies in patients with upper-extremity deep vein thrombosis. Central European Journal of Immunology. 40(3). 307–310. 4 indexed citations
7.
Baleva, Marta, et al.. (2014). Clinical immunology<br>Bouquet variety of antiphospholipid antibodies in recurrent pregnancy loss. Central European Journal of Immunology. 39(3). 352–356. 3 indexed citations
8.
Baleva, Marta, et al.. (2013). Blue toe syndrome as the initial manifestation of ANCA-associated vasculitis. SHILAP Revista de lepidopterología. 8(5). 577–579.
9.
Dourmishev, Lyubomir, et al.. (2013). Role of the Promoter Polymorphism IL-6 −174G/C in Dermatomyositis and Systemic Lupus Erythematosus. BioMed Research International. 2013. 1–5. 13 indexed citations
10.
Baleva, Marta, et al.. (2012). The Coexistence of Systemic Lupus Erythematosus and Thyrotoxicosis: The Diagnostic Value of Antihistone Antibodies. SHILAP Revista de lepidopterología. 2012. 1–4. 3 indexed citations
11.
Mihaylova, Nikolina, Ivan Grozdev, Marta Baleva, et al.. (2011). Elimination of autoreactive B cells in humanized SCID mouse model of SLE. European Journal of Immunology. 41(11). 3301–3311. 16 indexed citations
12.
Baleva, Marta, et al.. (2011). Alteration of secretory IgA in human breast milk and stool samples after the intake of a probiotic — report of 2 cases. SHILAP Revista de lepidopterología. 7(1). 25–29. 4 indexed citations
13.
Baleva, Marta, et al.. (2011). The Role of Intravenous Immunoglobulin Preparations in the Treatment of Systemic Sclerosis. International Journal of Rheumatology. 2011. 1–4. 17 indexed citations
14.
Baleva, Marta, et al.. (2009). Diagnostic significance of anti-annexin-A5 antibody determination. Open Medicine. 5(1). 6–11. 2 indexed citations
15.
Voynova, Elisaveta, Andrey Tchorbanov, József Prechl, et al.. (2008). An antibody-based construct carrying DNA-mimotope and targeting CR1(CD35) selectively suppresses human autoreactive B-lymphocytes. Immunology Letters. 116(2). 168–173. 25 indexed citations
16.
Ramshev, K., et al.. (2008). Serum lipids, uric acid and leptin/adiponectin ratio in clinically healthy normal weight and overweight young men, aged 17–20 years. Journal of Men s Health. 6(1). 63–69. 2 indexed citations
17.
Baleva, Marta, et al.. (2007). Some Recent Insights into the Prothrombogenic Mechanisms of Antiphospholipid Antibodies. Current Medicinal Chemistry. 14(7). 811–826. 8 indexed citations
18.
Kamenov, Zdravko, et al.. (2004). Anticardiolipin antibodies during hormone replacement therapy in healthy postmenopausal women. Maturitas. 48(4). 393–397. 5 indexed citations
19.
Dobreva, Gergana, et al.. (2000). Protein C Activity in Patients with Antiphospholipid Syndrome. JCR Journal of Clinical Rheumatology. 6(5). 239–243. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026